PHESGO
PHESGO
Approved
DIN Number
02512912
Drug Class
Human
Market Date
Apr 8, 2021
Company
HC
Hoffmann-La Roche Limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02512912
AIG Number0254251002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L01FY01 PERTUZUMAB AND TRASTUZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (2)
PERTUZUMABActive
Strength: 80 MG / ML
Monograph: PERTUZUMAB
TRASTUZUMABActive
Strength: 40 MG / ML
Monograph: TRASTUZUMAB